The success of Viagra initially drove a period of growth for pharma, but recent shifts present a murky scenario for investors. Lower-cost alternatives are eroding revenue, and ongoing legal battles add additional https://nanniemlac570598.dreamyblogs.com/41489347/the-blue-pill-and-pharma-a-risky-play